Search
Follow us: 
 
Business Operations > Benchmarking and Quality

Benchmarking and Quality Best Practices

Best Practices, LLC has conducted extensive research in the field of Benchmarking and Quality. Browse through and sample our published Benchmarking and Quality research in the topics below:


      View all Benchmarking and Quality research
 
Strategic KOL Management: Coordination, Software and Thought Leader IdentificationThis document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to review a complimentary excerpt from "Strategic KOL Management: Coordination, Software and Thought Leader Identification" STUDY OVERVIEW In the face of changes in the regulatory and access landscape, pharmaceutical organizations can no longer afford to have multiple functions and regions blindly contacting the same Key Opinion Leader (KOL). For any number of reasons – efficiency and courtesy are two obvious ones – organizations should have a KOL management system that ensures coordinated interactions. An organization's CRM software clearly plays a role in this. Best Practices, LLC conducted this research to help organizations create and maintain a strategic KOL management system. In particular, this study examines current approaches to coordination, software and thought leader identification for a strategic KOL management system. This study provides an evidence-based understanding of current and evolving approaches to creating and maintaining an integrated, strategically-focused KOL management system. KEY TOPICS Coordinating and Communicating Strategic Thought Leader Management and Engagement Aligning Software Tools to Support Strategic Thought Leader Management and Engagement Identifying and Engaging Thought Leaders KEY METRICS Functional areas that conduct strategic KOL management activities (across indicated product lifecycle periods) Most effective approaches to coordination of KOL management activities Communication channels your organization uses to share best practices across the organization Frequency of nonfield-based strategic KOL management staff interactions with KOLs Software programs/systems utilized by your organization Do you utilize a system with a global line of sight for all KOL activities Involvement level of MSLs in KOL identification Importance rating of 8 KOL services KOL activities most valued by organization SAMPLE KEY FINDING Respondents recognized the importance having a platform for sharing learning/best practices among the staff involved in strategic KOL management. Almost half of respondents said they use quarterly in-person meetings while nearly a third utilize an online database/spreadsheet. METHODOLOGY Thirty-four TL management leaders from 29 biopharma and device organizations participated in the external field survey, and we interviewed 4 participants for in-depth insights

Preparing Medical Science Liaison Teams for a Changing Environment: Value and BudgetThis document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to review a complimentary excerpt from "Preparing Medical Science Liaison Teams for a Changing Environment: Value and Budget" STUDY OVERVIEW Their interactions with thought leaders have made Medical Science Liaisons an important part of biopharmaceutical companies' clinical programs. Best Practices, LLC conducted this benchmarking study to provide leading insights on the value associated with MSLs’ responsibilities and how MSL team budgets are allocated. This study captures wide-ranging insights and metrics that will help Medical Affairs leaders to demonstrate the value of their MSL teams and to compare their budget allocations with peers in the industry. Companies can use this study to improve the effectiveness of their Medical Science Liaison teams. KEY TOPICS Medical Liaisons: Leadership and Value Medical Liaisons: Resources and Budget SAMPLE KEY METRICS Medical science liaisons leadership Value associated with Medical science liaison responsibilities for mature and emerging markets Level of outsourcing at MSL teams Factors affecting annual MSL team budgets Breakdown of MSL team budget at mature and emerging markets SAMPLE KEY FINDING Value Associated with Medical Science Liaisons’ Responsibilities: Internal stakeholders find value in responsibilities related to medical communication with key influencers and internal support for sales & marketing activities. While perceived value for medical communication with external stakeholders is seen as high, there is less perceived value for the internal support for sales & marketing among internal stakeholders. METHODOLOGY This study engaged executives from 32 leading healthcare companies. Segmentation analysis was key to examining trends and effective practices. Twenty three participants make up the Mature Markets Segment, while the Emerging Markets Segment consists of seven participants from Brazil, India and other Asia markets. This report includes Mature and Emerging Markets segments’ analysis.

Preparing Medical Science Liaison Teams for a Changing Environment: Team Size and DeploymentThis document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to review a complimentary excerpt from "Preparing Medical Science Liaison Teams for a Changing Environment: Team Size and Deployment" STUDY OVERVIEW Medical Science Liaison (MSL) teams face a rapidly changing healthcare environment that requires organizations to have their MSL teams appropriately sized and deployed. Best Practices, LLC conducted this research to identify the drivers of MSL team size and explore factors affecting deployment. Insights and metrics in the study will help companies field a more efficient and effective medical field team. KEY TOPICS Medical Liaisons: Size Of Medical Science Liaison Teams Medical Liaisons: Effective Operations Of Medical Science Liaison Teams SAMPLE KEY METRICS Regional demographics of participants Title of respondents Geographic span of responsibility of medical affairs at participating companies Product scope of MSLs Factors to determine team size Internal stakeholder needs Deployment of medical liaisons into the field in mature and emerging markets Factors causing increase in the number of medical science liaisons Factors causing decrease in the number of medical science liaisons SAMPLE KEY FINDING Determining Medical Science Liaison Teams’ Size: Mature Markets and Emerging Markets companies employ different strategies when determining the size of Medical Science Liaisons. Mature markets companies use company or product related factors such as “Corporate Commitment to a Franchise” or “Product Life Cycle” more often than Emerging Markets companies. Emerging Markets companies typically use an external factor, “Number of Thought Leaders,” to determine Medical Science Liaison teams’ size. METHODOLOGY This study engaged executives from 32 leading healthcare companies. Segmentation analysis was key to examining trends and effective practices. Twenty three participants make up the Mature Markets Segment, while the Emerging Markets Segment consists of seven participants from Brazil, India and other Asia markets. This report includes Mature and Emerging Markets segments’ analysis.

 


 
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE
Quick Links
About Us | Contact Us | Faq | Share Your Suggestion | Sitemap
Follow us: 



All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information